Loading clinical trials...
Loading clinical trials...
The objective of the study will be to understand whether a supplementation of the diet with an active symbiotic, i.e. characterized by a mix of probiotics and a specially selected fiber with prebiotic...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institute of Biomedical Technologies-National Research Council, Italy
Collaborators
NCT07294144 · ALS (Amyotrophic Lateral Sclerosis)
NCT07233148 · Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND), and more
NCT07369076 · Amyotrophic Lateral Sclerosis (ALS)
NCT07654205 · Attention Deficit/Hyperactivity Disorder(ADHD), Alcohol Use
NCT03489278 · Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia, and more
Scientific Institute IRCCS Eugenio Medea
Bosisio Parini, LC
Alessia Fumagalli
Casatenovo, LC
IBBA-CNR
Milan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions